Header Logo

Connection

Alan Rosmarin to Antigens, CD20

Back to Details
This is a "connection" page, showing publications Alan Rosmarin has written about Antigens, CD20.
Alan Rosmarin
Connection Strength
0.095
Antigens, CD20
  1. Reagan JL, Rosmarin A, Butera JN, Nadeem A, Schiffman FJ, Sikov WM, Winer E, Mega AE. Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL. Cancer Chemother Pharmacol. 2011 Oct; 68(4):1075-80.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.